421 citations
Cite
SaveGo to paper →
Elsevier
Journal of Virus Eradication Template
Write in a clean editor, then format for Journal of Virus Eradication in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Journal of Virus Eradication format
Journal of Virus Eradication is a peer-reviewed journal published by Elsevier, covering HIV Research and Treatment, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Journal of Virus Eradication 12 (2023) 45–58.
Formats any DOI in Journal of Virus Eradication style. No sign-up. |
| Publishes research in | HIV Research and Treatment HIV/AIDS Research and Interventions HIV/AIDS drug development and treatment Hepatitis C virus research HIV-related health complications and treatments |
| ISSN | 2055-6640 |
| Citation impact (2-yr) | 0.57 |
| h-index | 42 |
| i10-index | 188 |
| Total citations | 7,788 |
| Article processing charge | $1,950 |
| Open access | Yes |
| Top institutions publishing here | University of North Carolina at Chapel Hill |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Journal of Virus Eradication per year
Citation impact of Journal of Virus Eradication by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Journal of Virus Eradication
Repurposing broad-spectrum antivirals is an immediate treatment opportunity for 2019 coronavirus disease (COVID-19). Favipiravir is an antiviral previously indicated for influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19. We aim to review existing favipiravir safety evidence, which is vital to informing the potential future use of favipiravir in…
278 citations
Cite
SaveGo to paper →
Higher plasma tenofovir concentrations are associated with higher risks of renal and bone adverse events. The pharmacokinetic boosters ritonavir (RTV) and cobicistat (COBI) significantly increase plasma area under the curve (AUC) concentrations of tenofovir disoproxil fumarate (TDF), by 25–37%. When combined with RTV or COBI, the dose of tenofovir alafenamide (TAF) is lowered from 25…
131 citations
Cite
SaveGo to paper →
BACKGROUND: Hepatitis C (HCV) can only be eradicated if annual rates of cure (SVR) are consistently and significantly higher than new HCV infections, across many countries. In 2016, the WHO called for a 90% reduction in new HCV infection by 2030. Direct-acting antivirals (DAA) can cure the majority of those treated, at around 90% in…
131 citations
Cite
SaveGo to paper →
There is great concern about the impact of COVID-19 among the nearly 40 million people living with HIV (PLWH) worldwide. In this review, we surveyed current literature and found no evidence of higher prevalence of COVID-19 among PLWH but equivocal data on increased mortality and worse clinical outcomes. Having HIV does not confer protection against…
110 citations
Cite
SaveGo to paper →
Related journal templates
Journal of Virus Eradication template — frequently asked questions
How do I write a paper in the Journal of Virus Eradication format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Journal of Virus Eradication template. When you export, DocuGuru compiles the paper into the official Elsevier format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Journal of Virus Eradication use?
Journal of Virus Eradication uses Numbered (Elsevier) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: [1] A. Smith, B. Jones, C. Lee, A representative article title, Journal of Virus Eradication 12 (2023) 45–58.
Do I need to know LaTeX to submit to Journal of Virus Eradication?
No. DocuGuru generates the elsarticle LaTeX class and compiles the PDF for you in the background, so you get a Elsevier-ready Journal of Virus Eradication document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Journal of Virus Eradication template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Journal of Virus Eradication format with correct headings, figures, tables, and numbered citations.
Who publishes Journal of Virus Eradication?
Journal of Virus Eradication is a multidisciplinary journal published by Elsevier. DocuGuru's Journal of Virus Eradication template matches Elsevier's official submission format.
Can I export a submission-ready Journal of Virus Eradication PDF?
Yes — DocuGuru produces a PDF built with the official Journal of Virus Eradication template (the elsarticle class) that is ready to submit to Elsevier, together with the matching LaTeX source files.
How much does the Journal of Virus Eradication template cost?
You can start writing in the Journal of Virus Eradication template for free. Exporting the final submission-ready Journal of Virus Eradication PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.